Clinical Trial Update: to Evaluate the Efficacy and Safety of KLH-2109 in Patients With Uterine Fibroids and Menorrhagia [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating the efficacy and safety of KLH-2109 in patients with uterine fibroids and menorrhagia, with recruitment ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Menorrhagia
• Uterine Fibroids

Drugs mentioned

• KLH-2109

Snippet

Sponsor: JW Pharmaceutical | Conditions: Menorrhagia, Uterine Fibroids | Phase 3 | Status: RECRUITING